Avricore Health (AVCRF) Invested Capital (2014 - 2025)

Avricore Health (AVCRF) has 12 years of Invested Capital data on file, last reported at $279351.0 in Q4 2025.

• Invested Capital for Q4 2025 came in at $279351.0, down 80.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $279351.0 (down 80.17% YoY), and the FY2025 annual result was $278819.3, down 80.6% from the prior year.
• Invested Capital fell to $279351.0 in Q4 2025 per AVCRF's latest filing, from $1.4 million in the prior quarter.
• Over five years, Invested Capital peaked at $2.0 million in Q1 2021 and troughed at $29587.9 in Q1 2023.
• A 5-year average of $899622.6 and a median of $843973.3 in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2021 and 2022: Invested Capital soared 733.65% in 2021, then plunged 98.44% in 2022.
• A 5-year view of Invested Capital shows it stood at $1.8 million in 2021, then fell by 16.8% to $1.5 million in 2022, then climbed by 9.69% to $1.6 million in 2023, then slipped by 13.02% to $1.4 million in 2024, then plunged by 80.17% to $279351.0 in 2025.
• Business Quant data shows AVCRF's Invested Capital at $279351.0 in Q4 2025, $1.4 million in Q4 2024, and $1.6 million in Q4 2023.